Community Health Systems Announces Proposed Exchange Offer and Consent Solicitation
The proposed new notes would become redeemable at 101.000% of principal on November 15, 2027, and at 100.000% a year later.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
In addition, the Issuer intends to solicit consents (“Consents” and such solicitation, the “Consent Solicitation”) from eligible holders of the Old Notes to adopt certain proposed amendments (the “Proposed Amendments”) to the indenture governing the Old Notes (the “Old Notes Indenture”), to eliminate substantially all restrictive covenants, certain events of default and certain other provisions contained in the Old Notes Indenture. The Supporting Holders (as defined below) who have entered into the Support Agreement (as defined below) collectively hold a majority of the outstanding principal amount of Old Notes, which means the Issuer expects to have the necessary consents to adopt the Proposed Amendments, assuming the consummation of the Exchange Offer and the Consent Solicitation.
Pursuant to the Exchange Offer, in exchange for each
Title of Old Notes |
CUSIP/ISIN |
Aggregate Principal Amount of Old Notes Outstanding |
New Notes to be Issued in Exchange for Old Notes |
Exchange Consideration |
Early Tender Premium |
Total Consideration, if validly tendered (and not validly withdrawn) at or prior to the Early Tender Deadline |
Secured Notes due 2029 |
144A: 12543D BJ8 / US12543DBJ81
Reg S: U17127 AT5 / USU17127AT51 |
|
Secured Note due 2035 |
|
|
|
The Issuer has entered into an exchange offer support agreement (the “Support Agreement”) with certain institutional investors that are holders of the Old Notes (the “Supporting Holders”) pursuant to which such Supporting Holders have agreed, subject to the satisfaction of certain conditions, to tender (and not withdraw) approximately
In addition, holders whose Old Notes are exchanged in the Exchange Offer will receive accrued and unpaid interest in cash in respect of their exchanged Old Notes from the last interest payment date to, but not including, the settlement date for the Exchange Offer (which date will be described in the Offering Memorandum).
The Exchange Offer and the Consent Solicitation will be subject to certain conditions as will be set forth in the Offering Memorandum, including (i) in the case of the Consent Solicitation, the receipt of the Requisite Consents (as defined in the Offering Memorandum) and (ii) Supporting Holders validly tendering (and not validly withdrawing) the approximately
If, after the Expiration Date, all conditions to the Exchange Offer and the Consent Solicitation have been or concurrently are or will be satisfied or waived by the Issuer, the Issuer will accept for exchange all Old Notes validly tendered (and not validly withdrawn) in the Exchange Offer at or prior to the Expiration Date. Subject to the terms and conditions of the Exchange Offer, it is expected that the settlement date will promptly follow the Expiration Date and is currently expected to be on the second business day after the Expiration Date.
It is expected that the New Notes will bear interest at a rate of
It is expected that the indenture governing the New Notes will contain covenants substantially similar to those included in the Issuer’s outstanding
It is expected that the New Notes will be guaranteed on a senior secured basis by the Company and certain of its existing and future domestic subsidiaries that guarantee the Issuer’s outstanding ABL facility and senior notes. In addition, the New Notes and related guarantees are expected to be secured by (i) shared first-priority liens on the collateral that secures the Issuer’s existing secured notes and (ii) shared second-priority liens on the collateral that secures the Issuer’s outstanding ABL facility, in each case subject to permitted liens and certain exceptions as will be described in the Offering Memorandum.
The Issuer is under no obligation to commence the Exchange Offer or the Consent Solicitation. There can be no assurance that the Exchange Offer or the Consent Solicitation will be commenced or consummated on the terms described in this press release or at all. The complete terms and conditions of the Exchange Offer and the Consent Solicitation will be set forth in an offering memorandum and consent solicitation statement (the “Offering Memorandum”) which will be made available to eligible holders of Old Notes in connection with the proposed Exchange Offer and Consent Solicitation.
This press release is issued pursuant to Rule 135c under the Securities Act of 1933, as amended (the “Securities Act”). The New Notes and related guarantees will not be registered under the Securities Act or any state securities laws. The New Notes may not be offered or sold in
This press release is for informational purposes only. This press release is neither an offer to sell nor a solicitation of an offer to buy any New Notes and is neither an offer to purchase nor a solicitation of an offer to sell any Old Notes or 2030 Junior-Priority Secured Notes and is not a solicitation of consents with respect to the Old Notes. The Exchange Offer and the Consent Solicitation will be made only by, and pursuant to, the terms to be set forth in the Offering Memorandum. The Exchange Offer and the Consent Solicitation will not be made to persons in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. Documents relating to the Exchange Offer and the Consent Solicitation, including the Offering Memorandum, will only be distributed to eligible holders who complete and return an eligibility form confirming they are either (i) a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or (ii) not a
Forward-Looking Statements
Statements contained in this press release regarding the proposed Exchange Offer and the Consent Solicitation described herein are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261109735753/en/
Investor Contacts:
Kevin J. Hammons
Chief Executive Officer
(615) 465-7000
Anton Hie
Vice President – Investor Relations
(615) 465-7012
Source: Community Health Systems, Inc.